Earnings call transcript: Plus500 H1 2026 results lift shares 6% on growth

Plus500 reported record H1 2026 results: revenue rose 12% YoY to ~$463M and customer income jumped 24% YoY to ~$461M, while basic EPS increased 6% YoY to $2.17 and EBITDA edged up 1% YoY to $187.5M (EBITDA margin 41%). The company ended the period with ~$860M cash and zero debt, generated 99% operating cash conversion, and announced additional shareholder returns of $182.5M ($82.5M dividends and $100M new buybacks). Shares rose 6.07% to $3,984 as investors appeared to reward the stronger cash generation and scaling momentum in non-OTC futures/prediction markets (non-OTC revenue nearly doubled to ~$70M in H1 2026, up from ~$35M in H1 2024) while management reiterated full-year 2026 results remain on track.

Analysis

The near-term read-through is constructive for PLSQF, but the cleanest implication is not “earnings beat” so much as a higher-quality mix shift that can re-rate the multiple if it persists. The market is likely underestimating how much of the current growth is becoming recurring infrastructure revenue rather than pure trading beta; that matters because it reduces dependence on volatile OTC activity and makes buybacks more sustainable. The flip side is that the margin step-down from reinvestment means this is still a story of future operating leverage, not present-day peak profitability.

Second-order, the competitive threat is less to the big exchanges’ core futures franchises and more to niche fintech/CFD peers that rely on weaker retention and less integrated product stacks. CME and ICE can still benefit indirectly if prediction markets keep expanding regulated volumes, but Plus500’s B2B2C/cross-sell model is more disruptive to smaller platforms that cannot replicate licensing plus clearing plus distribution. The biggest hidden asset is customer deposit stickiness: if deposit growth holds, it effectively funds customer acquisition and creates a self-financing growth loop.

Catalyst path: 1-3 months, expect the stock to trade on whether H2 data confirms operating leverage and whether the new channels show real volume, not just press-release partnerships. 6-18 months, the key falsifier is a stall in non-OTC revenue growth or a regulatory stumble in prediction markets/U.S. futures that caps scalability. Contrarian take: the move may still be underdone because investors often misprice platform businesses with strong cash conversion as if they were just cyclicals; however, if marketing spend stays elevated and volume growth normalizes, the current optimism can unwind quickly.

Key Decisions for Investors

• Long PLSQF on pullbacks, 1-3 month horizon; thesis is that the market will reward mix-shift and buyback support if H2 volumes confirm. Risk/reward improves if shares hold above the post-print breakout zone and management reiterates full-year expectations.
• If already long, use a trailing hedge rather than selling outright: buy puts or reduce into strength if the stock approaches the upper end of its 52-week range before H2 trading data is visible. Falsifier: customer-income growth and deposits decelerate for two straight months.
• Pair trade idea: long PLSQF / short CME or ICE in a small relative-value basket only if you want to isolate higher growth versus lower-beta exchange exposure. This is a growth-vs-quality hedge, not a macro call; exit if prediction-market/regulatory headlines widen the gap in favor of exchanges.
• Watch item, not a trade yet: assess whether non-OTC margins converge toward management’s 20%+ target over the next 2 quarters. If they do not, the market should discount the long-term story and the re-rating case weakens materially.